 BAUDETTE, Minn.--BUSINESS WIRE--ANI Pharmaceuticals, Inc. ANI or the Company Nasdaq: ANIP today announced U.S. Food and Drug Administration FDA approval and the launch of Aminocaproic Acid Tablets USP, 500mg. The current annual U.S. market for this product is approximately 12.7 million, according to IQVIAIMS Health. This is ANIs seventh generic product launch in 2020 and reaffirms our commitment to increasing the pace of market introductions for our products. This important ther 